SARS-CoV-2 epitope recognition, it may be possible to suggest effective antibody combinations for therapeutic use and better understand the immune response to the virus. Neutralization assays Laboratory-based neutralization assays have seen widespread use by researchers investigating SARSCoV-2. These include assays using the live virus, or a pseudotype, to infect mammalian cells-that must be performed under strict biosafety level 3 (BSL-3) conditions-and a broad range of 'surrogate' ELISAs. The clone CR3022 is frequently employed as a reference in these studies, where it provides an essential benchmark against which potential therapeutic candidates can be assessed. antibodies-online offers a diverse portfolio of reagents for studying SARS-CoV-2, including the CR3022 clone. These are complemented by a SARSCoV-2 Mutations Tracker for sourcing the very latest mutation-specific antibodies, proteins, and assays. To learn more visit antibodies-online.com Additional Resource SARS-CoV-2 Spike S1 antibody (RBD) 39http://www.antibodies-online.com https://www.antibodies-online.com/antibody/6952546/anti-SARS-CoV-2+Spike+S1+RBD+antibody/